Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study

Fundam Clin Pharmacol. 2018 Apr;32(2):206-208. doi: 10.1111/fcp.12353.

Authors

Paul Carrier^{1

2

3}, Véronique Loustaud-Ratti^{1

2

3}

Affiliations

¹ Hepatology and Gastroenterology Unit, Limoges Teaching Hospital, 2, avenue Martin Luther King, 87042, Limoges, France.
² Faculté de Médecine et de Pharmacie de Limoges, INSERM, UMR-1248, 2, rue Docteur Marcland, 87042, Limoges, France.
³ FHU SUPORT (SUrvival oPtimization in ORgan Transplantation), 2, avenue Martin Luther King, 87042, Limoges, France.

PMID: 29430750
DOI: 10.1111/fcp.12353

No abstract available

Publication types

Editorial

MeSH terms

Hepatic Encephalopathy / drug therapy*
Hepatic Encephalopathy / etiology*
Humans
Intensive Care Units
Liver Cirrhosis / complications*
Phenylbutyrates / therapeutic use*

Substances

Phenylbutyrates
4-phenylbutyric acid